- Home
- AIXI vs ITRM Comparison
AIXI vs ITRM Comparison
Compare AIXI & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIXI
- ITRM
- Stock Information
- Founded
- AIXI 2001
- ITRM 2015
- Country
- AIXI China
- ITRM Ireland
- Employees
- AIXI N/A
- ITRM N/A
- Industry
- AIXI Computer Software: Prepackaged Software
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- AIXI Technology
- ITRM Health Care
- Exchange
- AIXI Nasdaq
- ITRM Nasdaq
- Market Cap
- AIXI 35.4M
- ITRM 36.3M
- IPO Year
- AIXI 2023
- ITRM 2018
- Fundamental
- Price
- AIXI $3.39
- ITRM $0.93
- Analyst Decision
- AIXI
- ITRM Strong Buy
- Analyst Count
- AIXI 0
- ITRM 2
- Target Price
- AIXI N/A
- ITRM $7.00
- AVG Volume (30 Days)
- AIXI 174.9K
- ITRM 661.0K
- Earning Date
- AIXI 05-15-2025
- ITRM 05-13-2025
- Dividend Yield
- AIXI N/A
- ITRM N/A
- EPS Growth
- AIXI N/A
- ITRM N/A
- EPS
- AIXI N/A
- ITRM N/A
- Revenue
- AIXI $70,314,315.00
- ITRM N/A
- Revenue This Year
- AIXI $26.84
- ITRM N/A
- Revenue Next Year
- AIXI N/A
- ITRM $108.39
- P/E Ratio
- AIXI N/A
- ITRM N/A
- Revenue Growth
- AIXI 18.84
- ITRM N/A
- 52 Week Low
- AIXI $2.06
- ITRM $0.81
- 52 Week High
- AIXI $9.81
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- AIXI 48.56
- ITRM 39.47
- Support Level
- AIXI $3.05
- ITRM $0.89
- Resistance Level
- AIXI $3.89
- ITRM $1.03
- Average True Range (ATR)
- AIXI 0.42
- ITRM 0.07
- MACD
- AIXI -0.00
- ITRM -0.00
- Stochastic Oscillator
- AIXI 35.04
- ITRM 18.18
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.